Estonia vs Myanmar: Previously treated cases tested for RR-/MDR-TB
Estonia
94.0%
in 2024
Myanmar
94.0%
in 2024
Estonia rank
72nd
Myanmar rank
72nd
Previously treated cases tested for RR-/MDR-TB over time
- Estonia
- Myanmar
How they compare
Estonia currently reports 94.0% against 94.0% in Myanmar, a difference of 0.0%.
The two have swapped places 3 times across 15 shared years of data; in 2006 it was Estonia ahead.
Estonia ranks 72nd and Myanmar ranks 72nd of 180 countries.
Across the 3 decades both report, Estonia averaged higher in 2 and Myanmar in 1.
Head to head by decade
| Decade | Estonia | Myanmar | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 80.0% | 8.9% | 71.1% | Estonia |
| 2010s | 83.5% | 64.1% | 19.4% | Estonia |
| 2020s | 90.0% | 92.8% | 2.8% | Myanmar |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Estonia or Myanmar?
- Estonia, at 94.0% against 94.0% in Myanmar as of 2024.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Estonia and Myanmar?
- 0.0%, with Estonia ahead.
- How many years of comparable data are there for Estonia and Myanmar?
- 15 years are reported by both, from 2006 to 2024.
- How do Estonia and Myanmar rank globally for previously treated cases tested for rr-/mdr-tb?
- Estonia ranks 72nd and Myanmar ranks 72nd of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.